miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review)

被引:2
|
作者
Mu, Hongxiang [1 ]
Zhang, Wenmao [1 ]
Qiu, Ye [1 ]
Tao, Ting [1 ]
Wu, Hongliang [1 ]
Chen, Zhuo [1 ]
Xu, Gaosheng [1 ]
机构
[1] Yueyang Maternal & Child Hlth Hosp, 693 Baling Rd, Yueyang 414000, Hunan, Peoples R China
基金
湖南省自然科学基金;
关键词
breast cancer; microRNA; biomarker; signaling pathway; treatment and prognosis; KAPPA-B; PATHWAY; PROLIFERATION; CELLS;
D O I
10.3892/ijo.2021.5196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer (BC) is one of the most common malignancies affecting women. BC is a heterogeneous disease that involves multiple oncogenic pathways and/or genetic alterations. MicroRNAs (miRNAs or miRs) are a type of small endogenous single-stranded RNA that pairs with the 3 ' untranslated region of target mRNAs to negatively regulate the gene expression of specific mRNA targets. miRNAs are thus involved in various cellular processes, including proliferation, differentiation, apoptosis, migration, metabolism and the stress response. Over the past decade, a number of studies have demonstrated that the expression levels of miRNAs are dysregulated in a number of types of cancer, including BC. In the present review, recent research on miRNAs involved in the occurrence and development of BC, as well as the current findings on miRNAs as potential biomarkers for BC are summarized. In addition, the association between miRNA dysregulation and BC development, and the current status of BC treatment and prognosis are discussed. Finally, several signaling pathways involved in the development of BC and the potential roles of miRNAs in these pathways are reviewed. The present review aims to provide insight into the roles of miRNAs in BC.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Suitability of Circulating miRNAs as Potential Prognostic Markers in Colorectal Cancer
    Ristau, Jonas
    Staffa, Juergen
    Schrotz-King, Petra
    Gigic, Biljana
    Makar, Karen W.
    Hoffmeister, Michael
    Brenner, Herrmann
    Ulrich, Alexis
    Schneider, Martin
    Ulrich, Cornelia M.
    Habermann, Nina
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (12) : 2632 - 2637
  • [22] Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer
    Gailhouste, Luc
    Gomez-Santos, Laura
    Ochiya, Takahiro
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 199 - 223
  • [23] Tumor progression markers associated with breast cancer
    Croce, MV
    Sala, C
    Segal-Eiras, A
    GYNECOLOGIC ONCOLOGY ISSUES IN THE 8TH IGCS MEETING OF BUENOS AIRES, 2000, : 65 - 69
  • [24] The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer
    Bertoli, Gloria
    Cava, Claudia
    Castiglioni, Isabella
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 : S34 - S39
  • [25] Cyr61 promotes breast tumorigenesis and cancer progression
    Miaw-Sheue Tsai
    Daphne F Bogart
    Jessica M Castañeda
    Patricia Li
    Ruth Lupu
    Oncogene, 2002, 21 : 8178 - 8185
  • [26] The role of ADAM17 in tumorigenesis and progression of breast cancer
    Shen, Hongyu
    Li, Liangpeng
    Zhou, Siying
    Yu, Dandan
    Yang, Sujin
    Chen, Xiu
    Wang, Dandan
    Zhong, Shanliang
    Zhao, Jianhua
    Tang, Jinhai
    TUMOR BIOLOGY, 2016, 37 (12) : 15359 - 15370
  • [27] MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
    Zhao, Lin
    Zheng, Xin-Yu
    ONCOTARGETS AND THERAPY, 2016, 9 : 4505 - 4516
  • [28] Potential utility of miRNAs for liquid biopsy in breast cancer
    Liu, Xiangrong
    Papukashvili, Dimitri
    Wang, Zhixiang
    Liu, Yan
    Chen, Xiaoxia
    Li, Jianrong
    Li, Zhiyuan
    Hu, Linjie
    Li, Zheng
    Rcheulishvili, Nino
    Lu, Xiaoqing
    Ma, Jinfeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Cyr61 promotes breast tumorigenesis and cancer progression
    Tsai, MS
    Bogart, DF
    Castañeda, JM
    Li, P
    Lupu, R
    ONCOGENE, 2002, 21 (53) : 8178 - 8185
  • [30] miRNAs — novel regulators in skin cancer
    M. Teresa Villanueva
    Nature Reviews Cancer, 2015, 15 (1) : 5 - 5